Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study.
暂无分享，去创建一个
H. Dombret | B. Quesnel | P. Hérait | C. Preudhomme | X. Thomas | K. Yee | C. Récher | N. Vey | C. Kahatt | C. Berthon | C. Roumier | K. Rezai | F. Lokiec | E. Raffoux | C. Gomez-Roca | M. Michallet | D. Taussig